FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040426907> ?p ?o ?g. }

• W3040426907 endingPage "513" @default.
• W3040426907 startingPage "504" @default.
• W3040426907 abstract "Summary The UK National Cancer Research Institute initiated a prospective study (UKCRN‐ID 1760) to assess the prognostic value of early fluorodeoxyglucose (FDG)‐positron emission tomography (PET)/computed tomography (CT) in diffuse large B‐cell lymphoma (DLBCL). In total, 189 patients with DLBCL treated with R‐CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) had baseline and post‐cycle‐2 PET (PET2) within a quality assurance framework. Treatment decisions were based on CT; PET2 was archived for central blinded reporting after treatment completion. The association of PET2 response with end‐of‐treatment CT, progression‐free (PFS) and overall survival (OS) was explored. The end‐of‐treatment complete response rate on CT was 83·9%, 75·0%, 70·5%, 40·4% and 36·4% for Deauville score (DS) 1 ( n = 34), 2 ( n = 39), 3 ( n = 46), 4 ( n = 56) and 5 ( n = 14) ( P < 0·001); and 64·1% and 50·0% for the maximum standardised uptake value (∆SUV max ) of ≥66% ( n = 168) and <66% ( n = 21), respectively ( P = 0·25). After a median 5·4 years of follow‐up, the 5‐year PFS was 69·4%, 72·8%, 76·7%, 71·2% and 47·6% by DS 1–5 ( P = 0·01); and 72·6% and 57·1% by ∆SUV max of ≥66% and <66% ( P = 0·03), respectively. The association with DS remained in multivariable analyses, and was consistent for OS. Early complete metabolic response (DS 1–3) at interim PET/CT after two cycles of R‐CHOP in DLBCL was associated with a higher end‐of‐treatment complete and overall response rate; however, only DS‐5 patients had inferior PFS and OS." @default.
• W3040426907 created "2020-07-10" @default.
• W3040426907 creator A5011398209 @default.
• W3040426907 creator A5022624109 @default.
• W3040426907 creator A5033041833 @default.
• W3040426907 creator A5050819642 @default.
• W3040426907 creator A5052597763 @default.
• W3040426907 creator A5053161231 @default.
• W3040426907 creator A5056345420 @default.
• W3040426907 creator A5064184281 @default.
• W3040426907 creator A5069202689 @default.
• W3040426907 creator A5088142566 @default.
• W3040426907 creator A5089158540 @default.
• W3040426907 date "2020-07-04" @default.
• W3040426907 modified "2023-10-16" @default.
• W3040426907 title "FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study" @default.
• W3040426907 cites W1912693401 @default.
• W3040426907 cites W1996193488 @default.
• W3040426907 cites W2035578984 @default.
• W3040426907 cites W2051650384 @default.
• W3040426907 cites W2054274023 @default.
• W3040426907 cites W2058015212 @default.
• W3040426907 cites W2067709915 @default.
• W3040426907 cites W2085022705 @default.
• W3040426907 cites W2098488028 @default.
• W3040426907 cites W2099874503 @default.
• W3040426907 cites W2119147717 @default.
• W3040426907 cites W2131047799 @default.
• W3040426907 cites W2131900456 @default.
• W3040426907 cites W2135432883 @default.
• W3040426907 cites W2138384559 @default.
• W3040426907 cites W2139789114 @default.
• W3040426907 cites W2145304413 @default.
• W3040426907 cites W2145453495 @default.
• W3040426907 cites W2150587745 @default.
• W3040426907 cites W2152345349 @default.
• W3040426907 cites W2153440334 @default.
• W3040426907 cites W2171356556 @default.
• W3040426907 cites W2172003817 @default.
• W3040426907 cites W2275941472 @default.
• W3040426907 cites W2469052042 @default.
• W3040426907 cites W2524351293 @default.
• W3040426907 cites W2553611564 @default.
• W3040426907 cites W2596050027 @default.
• W3040426907 cites W2606364858 @default.
• W3040426907 cites W2735487424 @default.
• W3040426907 cites W2742627598 @default.
• W3040426907 cites W2800320119 @default.
• W3040426907 cites W2928384177 @default.
• W3040426907 cites W2946457100 @default.
• W3040426907 cites W2989546915 @default.
• W3040426907 doi "https://doi.org/10.1111/bjh.16875" @default.
• W3040426907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32621535" @default.
• W3040426907 hasPublicationYear "2020" @default.
• W3040426907 type Work @default.
• W3040426907 sameAs 3040426907 @default.
• W3040426907 citedByCount "22" @default.
• W3040426907 countsByYear W30404269072021 @default.
• W3040426907 countsByYear W30404269072022 @default.
• W3040426907 countsByYear W30404269072023 @default.
• W3040426907 crossrefType "journal-article" @default.
• W3040426907 hasAuthorship W3040426907A5011398209 @default.
• W3040426907 hasAuthorship W3040426907A5022624109 @default.
• W3040426907 hasAuthorship W3040426907A5033041833 @default.
• W3040426907 hasAuthorship W3040426907A5050819642 @default.
• W3040426907 hasAuthorship W3040426907A5052597763 @default.
• W3040426907 hasAuthorship W3040426907A5053161231 @default.
• W3040426907 hasAuthorship W3040426907A5056345420 @default.
• W3040426907 hasAuthorship W3040426907A5064184281 @default.
• W3040426907 hasAuthorship W3040426907A5069202689 @default.
• W3040426907 hasAuthorship W3040426907A5088142566 @default.
• W3040426907 hasAuthorship W3040426907A5089158540 @default.
• W3040426907 hasBestOaLocation W30404269072 @default.
• W3040426907 hasConcept C126322002 @default.
• W3040426907 hasConcept C188816634 @default.
• W3040426907 hasConcept C199374082 @default.
• W3040426907 hasConcept C2775842073 @default.
• W3040426907 hasConcept C2776694085 @default.
• W3040426907 hasConcept C2776755627 @default.
• W3040426907 hasConcept C2777415128 @default.
• W3040426907 hasConcept C2778559949 @default.
• W3040426907 hasConcept C2778720950 @default.
• W3040426907 hasConcept C2779338263 @default.
• W3040426907 hasConcept C2779429289 @default.
• W3040426907 hasConcept C2779725641 @default.
• W3040426907 hasConcept C2780653079 @default.
• W3040426907 hasConcept C2989005 @default.
• W3040426907 hasConcept C71924100 @default.
• W3040426907 hasConceptScore W3040426907C126322002 @default.
• W3040426907 hasConceptScore W3040426907C188816634 @default.
• W3040426907 hasConceptScore W3040426907C199374082 @default.
• W3040426907 hasConceptScore W3040426907C2775842073 @default.
• W3040426907 hasConceptScore W3040426907C2776694085 @default.
• W3040426907 hasConceptScore W3040426907C2776755627 @default.
• W3040426907 hasConceptScore W3040426907C2777415128 @default.
• W3040426907 hasConceptScore W3040426907C2778559949 @default.
• W3040426907 hasConceptScore W3040426907C2778720950 @default.
• W3040426907 hasConceptScore W3040426907C2779338263 @default.

• next